BRAF(V600E) mutation impinges on gut microbial markers defining novel biomarkers for serrated colorectal cancer effective therapies

BACKGROUND: Colorectal cancer (CRC) harboring BRAF(V600E) mutation exhibits low response to conventional therapy and poorest prognosis. Due to the emerging correlation between gut microbiota and CRC carcinogenesis, we investigated in serrated BRAF(V600E) cases the existence of a peculiar fecal micro...

Descripción completa

Detalles Bibliográficos
Autores principales: Trivieri, Nadia, Pracella, Riccardo, Cariglia, Maria Grazia, Panebianco, Concetta, Parrella, Paola, Visioli, Alberto, Giani, Fabrizio, Soriano, Amata Amy, Barile, Chiara, Canistro, Giuseppe, Latiano, Tiziana Pia, Dimitri, Lucia, Bazzocchi, Francesca, Cassano, Dario, Vescovi, Angelo L., Pazienza, Valerio, Binda, Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7737386/
https://www.ncbi.nlm.nih.gov/pubmed/33317591
http://dx.doi.org/10.1186/s13046-020-01801-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7737386/
https://www.ncbi.nlm.nih.gov/pubmed/33317591
http://dx.doi.org/10.1186/s13046-020-01801-w

Ejemplares similares